Quick Answer
LEMAITRE VASCULAR INC reported Gross Profit of $178.54 million for fiscal year 2025.
LEMAITRE VASCULAR INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $178.54M | +18.3% |
| 2024 | $150.90M | +18.8% |
| 2023 | $127.05M | +21.1% |
| 2022 | $104.90M | +3.5% |
| 2021 | $101.38M | +19.8% |
| 2020 | $84.62M | +6.0% |
| 2019 | $79.85M | +8.0% |
| 2018 | $73.94M | +4.6% |
| 2017 | $70.70M | +12.3% |
| 2016 | $62.94M | +16.2% |
| 2015 | $54.17M | +11.8% |
| 2014 | $48.43M | +7.4% |
| 2013 | $45.12M | +10.4% |
| 2012 | $40.87M | +1.6% |
| 2011 | $40.23M | -3.6% |
| 2010 | $41.72M | +11.8% |
| 2009 | $37.30M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.95M | +23.6% | +2.2% |
| June 30, 2025 | $44.97M | +16.9% | +8.6% |
| March 31, 2025 | $41.42M | +13.0% | +11.4% |
| September 30, 2024 | $37.18M | +20.6% | -3.4% |
| June 30, 2024 | $38.47M | +19.9% | +4.9% |
| March 31, 2024 | $36.66M | +18.7% | +19.0% |
| September 30, 2023 | $30.82M | +22.9% | -4.0% |
| June 30, 2023 | $32.09M | +15.4% | +3.9% |
- LEMAITRE VASCULAR INC showed an increase of +18.3% in Gross Profit compared to the prior fiscal year.
- Over the 2009–2025 period, LEMAITRE VASCULAR INC’s gross profit has grown by 378.6% (from $37.30 million to $178.54 million).
- The most recent figure is from LEMAITRE VASCULAR INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: